MarkWide Research

Sale!

Livestock Vaccines Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

 

Livestock Vaccines Market
1) Introduction
Vaccines are one of the most important tools that we have to protect our livestock from disease. They help to keep our animals healthy and productive, and can save us money in the long run by preventing costly diseases from taking hold.

The vaccines market for livestock is a growing one, with more and more products becoming available to farmers and ranchers. There are vaccines for a wide variety of diseases, including some of the most common and costly ones that can affect livestock.

Some of the most popular vaccines for livestock include those for:

-Bovine Respiratory Syncytial Virus (BRSV)

-Bovine Viral Diarrhea Virus (BVDV)

-Foot-and-Mouth Disease (FMD)

-Haemophilus somnus

– infectious bovine rhinotracheitis (IBR)

-Johnes disease

-Leptospirosis

-Porcine Reproductive and Respiratory Syndrome (PRRS)

– Salmonella

Vaccines can be given to animals in a number of ways, including by injection, orally, or in the nose. The route of administration will vary depending on the vaccine and the animal being vaccinated.

Most vaccines require a booster shot after the initial vaccination to ensure that the animal is fully protected. The interval between booster shots will also vary depending on the vaccine and the animal.

Vaccines are an important part of keeping our livestock healthy, and the market for these products is growing. There are vaccines available for a wide variety of diseases, and they can be given to animals in a number of ways. Most vaccines require a booster shot after the initial vaccination to ensure full protection, and the interval between booster shots will vary depending on the vaccine and the animal.

2) Market Overview
#2 Market Overview

The global livestock vaccines market size was valued at USD 3.2 billion in 2018 and is projected to grow at a CAGR of 7.6% from 2019 to 2025. The market is driven by the outbreak of various diseases in livestock, which in turn, has raised the demand for livestock vaccines.

The need for food security has increased in the past few years owing to the growing population. The demand for livestock products, such as meat, milk, and eggs, has increased significantly, which has resulted in the expansion of the livestock industry. This, in turn, has increased the susceptibility of livestock to diseases. Various diseases, such as foot-and-mouth disease (FMD), swine flu, and avian flu, have a significant impact on the livestock industry. These diseases not only affect the health of animals but also result in huge economic losses to the livestock industry.

According to the World Organization for Animal Health (OIE), in 2017, the number of FMD outbreaks was the highest in the past 10 years. The disease affected more than 60 countries and resulted in the death of over two million animals. The outbreak of various diseases has raised the demand for livestock vaccines.

The market is segmented on the basis of animal type, disease type, and geography. On the basis of animal type, the market is segmented into cattle, poultry, swine, and others. The poultry segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the growing poultry industry and the increasing awareness about vaccination among poultry farmers.

On the basis of disease type, the market is segmented into FMD, swine flu, avian flu, and others. The avian flu segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing occurrence of avian flu.

The market has been segmented on the basis of geography into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. Asia-Pacific is projected to grow at the highest CAGR during the forecast

3) Market Drivers
The livestock vaccines market is expected to grow in the coming years owing to various factors. Some of the key drivers of this market are rise in demand for animal-derived food products, increase in awareness about animal health, and growth in the number of livestock.

The demand for animal-derived food products has been on the rise in recent years due to the growing population and the changing dietary habits of people. The consumption of meat and dairy products has increased significantly, which has led to an increase in the demand for livestock. This, in turn, is expected to drive the demand for livestock vaccines.

The awareness about animal health has also increased in recent years. This is due to the outbreak of various diseases such as foot-and-mouth disease, avian influenza, and swine flu. The awareness about these diseases has led to an increase in the demand for vaccines that can protect animals from these diseases.

The number of livestock has also been increasing in recent years. This is due to the growing demand for meat and dairy products. The increase in the number of livestock is expected to drive the demand for livestock vaccines.

The above factors are expected to drive the growth of the livestock vaccines market in the coming years.

4) Market Restraints
The global livestock vaccines market is expected to grow at a CAGR of 7.4% during the forecast period (2020-2025). The rising demand for meat and poultry products is the major factor driving the growth of the market. The growing awareness about the importance of animal health and the need to control the spread of zoonotic diseases are some of the other factors supporting the growth of the market. However, the high cost of vaccines and the stringent government regulations are some of the major factors restraining the growth of the market.

The high cost of livestock vaccines is one of the major factors restraining the growth of the market. Vaccines are expensive and the cost of vaccination varies from country to country. For instance, the cost of vaccination for foot-and-mouth disease in the UK is around £6 per animal. Similarly, in the US, the cost of vaccination for swine flu ranges from $6 to $20 per dose. These high costs are a major barrier for small-scale farmers and are preventing them from adopting livestock vaccines.

Stringent government regulations are another major factor restraining the growth of the market. The registration and approval process for livestock vaccines is very long and complicated. It can take up to 10 years for a vaccine to be approved for use. The strict regulations are hampering the entry of new players in the market and are restraining the growth of the market.

5) Market Opportunities
The livestock vaccines market is growing at a rapid pace. This is due to the increasing demand for safe and effective vaccines for livestock. The market is expected to grow at a CAGR of 7.5% from 2019 to 2024.

There are a number of factors driving the growth of the livestock vaccines market. These include the increasing prevalence of diseases in livestock, the growing demand for meat and dairy products, and the need for safe and effective vaccines.

The most common diseases that affect livestock include foot-and-mouth disease, swine flu, and avian influenza. These diseases can cause serious health problems in livestock and can even lead to death. vaccination is the only way to protect livestock from these diseases.

The growing demand for meat and dairy products is another factor driving the growth of the livestock vaccines market. The world population is growing at a rapid pace and the demand for meat and dairy products is also increasing. This is resulting in the increased demand for livestock.

The need for safe and effective vaccines is another factor driving the growth of the livestock vaccines market. There is a growing concern about the safety of meat and dairy products. This is leading to the demand for safe and effective vaccines for livestock.

The livestock vaccines market is segmented on the basis of type, disease, and geography.

On the basis of type, the market is segmented into live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, and others.

On the basis of disease, the market is segmented into foot-and-mouth disease, swine flu, avian influenza, and others.

On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The key players operating in the livestock vaccines market include Zoetis, Merck & Co., Inc., Bayer AG, Ceva Sante Animale, and others.

6) Market Segmentation
Market Segmentation

The global livestock vaccines market is segmented on the basis of technology, animal type, and geography.

On the basis of technology, the market is categorized into conventional and recombinant. The recombinant segment is estimated to grow at a higher CAGR, owing to the rising preference for this technology.

On the basis of animal type, the livestock vaccines market is classified into poultry, ruminants, swine, and others. The poultry segment is anticipated to grow at a higher CAGR, due to the increasing demand for poultry meat and products.

The global livestock vaccines market is segmented into five key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is expected to dominate the global livestock vaccines market, due to the presence of a large number of key players in the region. The market in Asia Pacific is expected to grow at the highest CAGR, owing to the increasing demand for livestock products in the region.

The key players in the global livestock vaccines market are Zoetis Inc. (US), Merck & Co., Inc. (US), Elanco Animal Health (US), Boehringer Ingelheim International GmbH (Germany), Ceva Sante Animale (France), and Virbac (France).

7) Competitive Landscape
The livestock vaccines market is highly competitive with a large number of players. The key players in the market are Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, and Virbac. These players are engaged in various activities such as research and development, product launches, and mergers and acquisitions, to gain a competitive edge in the market.

The global livestock vaccines market is expected to reach USD 7.75 billion by 2025 from USD 5.19 billion in 2020, at a CAGR of 8.8%. The increase in demand for animal-derived food products, the outbreak of zoonotic diseases, and the implementation of stringent government regulations regarding animal health are the major factors driving the growth of this market.

The key players in this market are Zoetis (US), Merck (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), and Virbac (France). These players are engaged in various activities such as research and development, product launches, and mergers and acquisitions, to gain a competitive edge in the market.

Zoetis is the leading player in the global livestock vaccines market. The company has a strong presence in the North American and European markets. Zoetis offers a wide range of livestock vaccines, including bovine, porcine, ovine, and poultry vaccines. The company has a strong portfolio of products and a wide geographical presence. In March 2020, the company acquired Abaxis, a leading provider of point-of-care veterinary diagnostic instruments and consumables. The acquisition strengthened Zoetis’ position in the point-of-care diagnostics market and expanded its portfolio of products.

Merck is another leading player in the global livestock vaccines market. The company has a strong presence in the North American and European markets. Merck offers a wide range of livestock vaccines, including bovine, porcine, ovine, and poultry vaccines. The company has a strong portfolio of products and a wide geographical presence. In September 2019, the company acquired Virco, a leading provider of vaccines for poultry. The acquisition strengthened Merck’s

8) Company Profiles
The livestock vaccines market is expected to grow at a CAGR of 7.4% during the forecast period (2019 – 2024). The key factors driving the growth of the market are the growing demand for animal-derived food products, rising awareness about animal health, and government initiatives to promote animal health.

The Asia-Pacific region is the largest market for livestock vaccines, followed by North America and Europe. The Asia-Pacific region is also the fastest-growing market for livestock vaccines, due to the growing demand for animal-derived food products, rising awareness about animal health, and government initiatives to promote animal health.

Some of the key players in the livestock vaccines market are Zoetis, Merck & Co., Inc., Ceva Sante Animale, Boehringer Ingelheim Vetmedica, Inc., and Elanco Animal Health.

Zoetis is the largest player in the livestock vaccines market. The company offers a wide range of vaccines for livestock, including bovine, porcine, ovine, caprine, and equine. Zoetis has a strong presence in the North American and European markets.

Merck & Co., Inc. is one of the leading players in the livestock vaccines market. The company offers a wide range of vaccines for livestock, including bovine, porcine, ovine, caprine, and equine. Merck & Co., Inc. has a strong presence in the North American and European markets.

Ceva Sante Animale is a leading player in the livestock vaccines market. The company offers a wide range of vaccines for livestock, including bovine, porcine, ovine, caprine, and equine. Ceva Sante Animale has a strong presence in the European market.

Boehringer Ingelheim Vetmedica, Inc. is a leading player in the livestock vaccines market. The company offers a wide range of vaccines for livestock, including bovine, porcine, ovine, caprine, and equine. Boehringer Ingelheim Vetmedica, Inc. has a strong presence in the North American and European markets

9) Future Outlook
The livestock vaccines market is expected to grow at a CAGR of 7.8% during the forecast period (2020–2025). The market is driven by the increasing demand for livestock products, the outbreak of diseases in livestock, and the increasing awareness about animal health.

The bovine segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the increasing demand for beef and dairy products, the outbreak of diseases in cattle, and the government support for the vaccination of cattle.

The poultry segment is expected to grow at the second-highest CAGR during the forecast period. This is attributed to the increasing demand for poultry products, the outbreak of diseases in poultry, and the government support for the vaccination of poultry.

The porcine segment is expected to grow at the third-highest CAGR during the forecast period. This is attributed to the outbreak of diseases in pigs and the government support for the vaccination of pigs.

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This is attributed to the increasing demand for livestock products, the outbreak of diseases in livestock, and the government support for the vaccination of livestock.

Some of the key players operating in the livestock vaccines market are Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Bioniche Animal Health (Canada), Ceva Sante Animale (France), and Boehringer Ingelheim (Germany).

10) Conclusion
The global livestock vaccines market is expected to reach USD 7.8 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 11.6%. The growth of this market is driven by the rising prevalence of livestock diseases, government initiatives to promote livestock vaccination, and the growing demand for animal-derived food products.

The poultry segment is expected to grow at the highest CAGR during the forecast period.

Poultry vaccines are used to protect chickens from various diseases, such as Newcastle disease, avian influenza, and infectious laryngotracheitis. These diseases cause high mortality in poultry, which leads to significant economic losses for poultry farmers. The growing poultry industry and the increasing awareness about the importance of vaccination are the major factors driving the growth of the poultry vaccines market.

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The region includes countries such as China, India, Japan, and Australia. The region is a major market for livestock vaccines due to the growing livestock population and the increasing prevalence of livestock diseases. The rapidly growing economies in the region are also expected to drive the growth of the market.

The major players in the livestock vaccines market are Zoetis (US), Merck (US), Elanco (US), Ceva (France), and Boehringer Ingelheim (Germany).

Zoetis is a leading player in the global livestock vaccines market. The company offers a wide range of vaccines for poultry, swine, cattle, and sheep. The company has a strong presence in the North American and European markets. Zoetis has a strong product portfolio and has a wide geographic reach.

Merck is another leading player in the global livestock vaccines market. The company offers vaccines for poultry, swine, cattle, and sheep. Merck has a strong presence in the North American and European markets. The company has a strong product portfolio and has a wide geographic reach.

Elanco is a leading player in the global livestock vaccines market. The company offers

Key Players Covered:

 

Merck & Co., Inc., Pfizer Inc., AgriLabs, Zoetis, Novartis AG, Boehringer Ingelheim, Bayer AG, Eli Lilly and Company, Virbac, Neogen Corporation, ImmuCell Corporation and other players.

Segmentation

 

 ATTRIBUTE

 

 DETAILS
 

By Animal Type

 

 

    • Cattle
    • Horse
    • Pigs
    • Sheep
    • Poultry
 

By Vaccine Type

 

 

    • Attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • DNA Vaccines
    • Others
 

By Route of Administration

 

 

    • Oral
    • Intravenous

 

 

 

By Disease Indication

 

 

    • Clostridial Diseases
    • Reproductive and Infertility Disease
    • Respiratory Disease
    • Others (Swine Fever, etc.)

 

 

 

By Distribution Channel

 

 

    • Veterinary Hospital Pharmacies
    • Regional Distribution Centers
    • Others

 

 

 

By Geography

 

 

    • North America (USA and Canada)
    • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
    • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
    • Latin America (Brazil, Mexico and Rest of Latin America)
    • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

 

 

 

 

By Animal Type

 

 

    • Cattle
    • Horse
    • Pigs
    • Sheep
    • Poultry

 

 

 

By Vaccine Type

 

 

    • Attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • DNA Vaccines
    • Others

 

 

 

By Route of Administration

 

 

    • Oral
    • Intravenous

 

 

 

By Disease Indication

 

 

    • Clostridial Diseases
    • Reproductive and Infertility Disease
    • Respiratory Disease
    • Others (Swine Fever, etc.)

 

 

 

By Distribution Channel

 

 

    • Veterinary Hospital Pharmacies
    • Regional Distribution Centers
    • Others

 

 

Merck & Co., Inc., Pfizer Inc., AgriLabs, Zoetis, Novartis AG, Boehringer Ingelheim, Bayer AG, Eli Lilly and Company, Virbac, Neogen Corporation, ImmuCell Corporation and other players.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF